Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco - A review

Journal of Oral Pathology and Medicine

Volumn 36, Issue 2, 2007, Pages 63-77

  Warnakulasuriya, K A A S ^a   Ralhan, R ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Carcinogenicity; Molecular lesions; Oral cancer; Pre cancer; Smokeless tobacco; Snuff

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DEATH ASSOCIATED PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FRAGILE HISTIDINE TRIAD PROTEIN; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16; PROTEIN P53; RAS PROTEIN;

CARCINOGENICITY; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA ADDUCT; DYSPLASIA; ENZYME ACTIVATION; ERYTHROPLASIA; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; IN VITRO STUDY; KERATINOCYTE; LEUKOPLAKIA; MOUTH CARCINOMA; MOUTH LESION; NONHUMAN; ONCOGENE; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SISTER CHROMATID EXCHANGE; SMOKELESS TOBACCO; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VERRUCOUS CARCINOMA; VOLUNTEER;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; DNA MUTATIONAL ANALYSIS; ERYTHROPLASIA; GENES, P53; GENOMIC INSTABILITY; HUMANS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; SEX DISTRIBUTION; TOBACCO, SMOKELESS;

EID: 33846144159     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00496.x     Document Type: Review

References (169)

1. Hoffmann D, Adams JD. Carcinogenic tobacco-specific N-nitrosamines in snuff and in the saliva of snuff dippers. Cancer Res 1981; 41: 4305-8.
2. Hoffmann D, Djordjevic MV. Chemical composition and carcinogenicity of smokeless tobacco. Adv Dent Res 1997; 11: 322-9.
3. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 2003; 3: 733-44.
4. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 2004; 5: 708.
5. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003; 58: 435-43.
6. Warnakulasuriya S. Smokeless tobacco and oral cancer. Oral Dis 2004; 10: 1-4.
7. Levy DT, Mumford EA, Cummings KM, Gilpin EA, Giovino G, Hyland A et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev 2004; 13: 2035-42.
8. Brunnenman K, Qi J, Hoffman D. Aging of oral moist snuff and the yields of tobacco-specific N-nitrosamines (TSNA). Valhalla, New York: American Health Foundation. http://www.tobacco.org/News/010622BostonRE.html.
9. Sundstrom B, Mornstad H, Axell T. Oral carcinomas associated with snuff dipping. Some clinical and histological characteristics of 23 tumours in Swedish males. J Oral Pathol 1982; 11: 245-51.
10. Hirsch JM, Sloberg K, Adell R, Zaterstrom U, Wallstrom M. Snuff induced cancer in Sweden. In: Proceedings of 3rd International Conference on smokeless tobacco. September 22-25, Stockholm, Sweden, 2002.
11. Zatterstrom UK, Svensson M, Sand L, Nordgren H, Hirsch JM. Oral cancer after using Swedish snus (smokeless tobacco) for 70 years - a case report. Oral Dis 2004; 10: 50-3.
12. Schildt EB, Eriksson M, Hardell L, Magnuson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 1998; 77: 341-6.
13. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998; 82: 1367-75.
14. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 89 - Smokeless Tobacco. Lyon: IARC, 2006.
15. Rosenquist K, Wennerberg J, Schildt E-B, Bladstrom A, Hansson BG, Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 991-8.
16. McGuirt WF, Wray AM. Oral carcinoma and smokeless tobacco use: a clinical profile. In: Smokeless tobacco or health. Bethesda: National Cancer Institute, NIH, 1993.
17. McGuirt WF. Snuff dipper's carcinoma. Arch Otolaryngol 1983; 109: 757-60.
18. Winn DM, Blot WJ, Shy CM, Pickle LW, Toledo A, Fraumeni JF Jr. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981; 304: 745-9.
19. Mattson ME, Winn DM. Smokeless tobacco: association with increased cancer risk. NCI Monogr 1989: 13-6.
20. World Health Organization. Globacan. Lyon: IARC, 2002.
21. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 85: Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. Lyon: IARC, 2004; 238.
22. Gupta PC, Mehta FS, Daftary DK et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol 1980; 8: 283-333.
23. Jafarey NA, Mahmood Z, Zaidi SH. Habits and dietary pattern of cases of carcinoma of the oral cavity and oropharynx. J Pak Med Assoc 1977; 27: 340-3.
24. Warnakulasuriya KAAS. Smoking and chewing habits in Sri Lanka. Implications for oral cancer and precancer. In: PC Gupta, JE Hamner, PR Murti, ed. Control of tobacco-related cancers and other diseases. International symposium. Bombay: Oxford University Press, 1992; 113-8.
25. Shrestha P, Ikeda N, Fukano H, Takai Y, Mori M. Oral mucosal lesions associated with tobacco and betel-chewing habits: A Napalese experience. Dent J Malays 1997; 18: 23-5.
26. Dikshit RP, Kanhere S. Tobacco habits and risk of lung, oropharyngeal and oral cavity cancer: a population-based case-control study in Bhopal, India. Int J Epidemiol 2000; 29: 609-14.
27. Balram P, Sridhar H, Rajkumar T et al. Oral cancer in southern India: the influence of smoking, drinking, pan-chewing and oral hygiene. Int J Cancer 2002; 98: 440-5.
28. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 37: Tobacco habits other than smoking; betelquid and areca-nut chewing; and some areca-nut-derived nitrosamines. Lyon: IARC, 1985; 188.
29. Elbeshir EI, Abeen HA, Idris AM, Abbas K. Snuff dipping and oral cancer in Sudan: a retrospective study. Br J Oral Maxillofac Surg 1989; 27: 243-8.
30. Idris AM, Ahmed HM, Malik MO. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 1995; 63: 477-80.
31. Ibrahim EM, Satti MB, Al Idrissi HY, Higazi MM, Magbool GM, Al Quorain A. Oral cancer in Saudi Arabia: the role of alqat and alshammah. Cancer Detect Prev 1986; 9: 215-8.
32. Brown A, Ravichandran K, Warnakulasuriya S. The unequal burden related to the risk of oral cancer in the different regions of the Kingdom of Saudi Arabia. Community Dent Health 2006; 23: 101-6.
33. Zaridze DG, Blettner M, Trapeznikov NN et al. Survey of a population with a high incidence of oral and oesophageal cancer. Int J Cancer 1985; 36: 153-8.
34. Roed-Petersen B, Pindborg JJ. A study of Danish snuff-induced oral leukoplakias. J Oral Pathol 1973; 2: 301-13.
35. Pindborg JJ. Oral cancer and precancer. Bristol: John Wright, 1980; 34-58.
36. Axell T, Andersson G, Larsson A. Oral mucosal findings associated with chewing tobacco in Sweden - a clinical and histological study. J Dent Assoc S Afr 1992; 47: 194-6.
37. Cullen JW, Blot W, Henningfield J, Boyd G, Mecklenburg R, Massey MM. Health consequences of using smokeless tobacco: summary of the Advisory Committee's report to the Surgeon General. Public Health Rep 1986; 101: 355-73.
38. Grady D, Greene J, Daniels TE et al. Oral mucosal lesions found in smokeless tobacco users. J Am Dent Assoc 1990; 121: 117-23.
39. Sinusas K, Coroso JG, Sopher MD, Crabtree BF. Smokeless tobacco use and oral pathology in a professional baseball organization. J Fam Pract 1992; 34: 713-8.
40. Offenbacher S, Weathers DR. Effects of smokeless tobacco on the periodontal, mucosal and caries status of adolescent males. J Oral Pathol 1985; 14: 169-81.
41. Wolfe MD, Carlos JP. Oral health effects of smokeless tobacco use in Navajo Indian adolescents. Community Dent Oral Epidemiol 1987; 15: 230-5.
42. Tyldesley WR. Tobacco chewing in English coal miners. A preliminary report. Br J Oral Surg 1971; 9: 21-8.
43. Mehta FS, Shroff BC, Gupta PC, Daftary DK. Oral leukoplakia in relation to tobacco habits. A ten-year follow-up study of Bombay policemen. Oral Surg Oral Med Oral Pathol 1972; 34: 426-33.
44. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer 1969; 24: 832-49.
45. Daftary DK, Murti PR, Bhonsle RB, Gupta PC, Mehta FS, Pindborg JJ. Oral precancerous lesions and conditions of tropical interest. In: SR Prabu, DF Wilson, DK Daftary, NW Johnson, ed. Oral diseases in the tropics. Oxford: OUP, 1992; 402-28.
46. Thomas G, Hashibe M, Jacob BJ et al. Risk factors for multiple oral premalignant lesions. Int J Cancer 2003; 107: 285-91.
47. Hashibe M, Mathew B, Kuruvilla B et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev 2000; 9: 639-45.
48. Reichart PA, Philipsen HP. Oral erythroplakia - a review. Oral Oncol 2005; 41: 551-61.
49. Axell T, Mornstad H, Sundstrom B. The relation of the clinical picture to the histopathology of snuff dipper's lesions in a Swedish population. J Oral Pathol 1976; 5: 229-36.
50. Hirsch JM, Heyden G, Thilander H. A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol 1982; 11: 387-98.
51. Greer RO Jr, Poulson TC. Oral tissue alterations associated with the use of smokeless tobacco by teen-agers. Part I. Clinical findings. Oral Surg Oral Med Oral Pathol 1983; 56: 275-84.
52. Axell TE. Oral mucosal changes related to smokeless tobacco usage: research findings in Scandinavia. Eur J Cancer B Oral Oncol 1993; 29B: 299-302.
53. Robertson PB, Walsh M, Greene J, Ernster V, Grady D, Hauck W. Periodontal effects associated with the use of smokeless tobacco. J Periodontol 1990; 61: 438-43.
54. Little SJ, Stevens VJ, LaChance PA et al. Smokeless tobacco habits and oral mucosal lesions in dental patients. J Public Health Dent 1992; 52: 269-76.
55. Kaugars GE, Riley WT, Brandt RB, Burns JC, Svirsky JA. The prevalence of oral lesions in smokeless tobacco users and an evaluation of risk factors. Cancer 1992; 70: 2579-85.
56. Tomar SL, Winn DM, Swango PA, Giovino GA, Kleinman DV. Oral mucosal smokeless tobacco lesions among adolescents in the United States. J Dent Res 1997; 76: 1277-86.
57. Stewart CM, Baughman RA, Bates RE. Smokeless tobacco use among Florida teenagers: prevalence, attitudes, and oral changes. Fla Dent J 1989: 60: 38-42.
58. Mornstad H, Axell T, Sundstrom B. Clinical picture of snuff dipper's lesion in Swedes. Community Dent Oral Epidemiol 1989; 17: 97-101.
59. Andersson G, Axell T. Clinical appearance of lesions associated with the use of loose and portion-bag packed Swedish snuff: a comparative study. J Oral Pathol Med 1989; 18: 2-7.
60. Jungell P, Malmstrom M. Snuff-induced lesions in Finnish recruits. Scand J Dent Res 1985; 93: 442-7.
61. Bhonsle RB, Murti PR, Daftary DK, Mehta FS. An oral lesion in tobacco-lime users in Maharashtra, India. J Oral Pathol 1979; 8: 47-52.
62. Stich HF, Parida BB, Brunnemann KD. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, Khaini-tobacco chewers and gudakhu users. Int J Cancer 1992; 50: 172-6.
63. Evstifeeva TV, Zaridze DG. Nass use, cigarette smoking, alcohol consumption and risk of oral and oesophageal precancer. Eur J Cancer B Oral Oncol 1992; 28B: 29-35.
64. Daniels TE, Hansen LS, Greenspan JS et al. Histopathology of smokeless tobacco lesions in professional baseball players. Associations with different types of tobacco. Oral Surg Oral Med Oral Pathol 1992; 73: 720-5.
65. Greer RO, Poulson TC, Boone ME, Lindenmuth JE, Crosby L. Smokeless tobacco-associated oral changes in juvenile, adult and geriatric patients: clinical and histomorphologic features. Gerodontics 1986; 2: 87-98.
66. Andersson G, Axell T, Larsson A. Histologic changes associated with the use of loose and portion-bag packed Swedish moist snuff: a comparative study. J Oral Pathol Med 1989; 18: 491-7.
67. Idris AM, Warnakulasuriya KA, Ibrahim YE, Nielsen R, Cooper D, Johnson NW. Toombak-associated oral mucosal lesions in Sudanese show a low prevalence of epithelial dysplasia. J Oral Pathol Med 1996; 25: 239-44.
68. Larsson A, Axell T, Andersson G. Reversibility of snuff dippers' lesion in Swedish moist snuff users: a clinical and histologic follow-up study. J Oral Pathol Med 1991; 20: 258-64.
69. Kaugars GE, Mehailescu WL, Gunsolley JC. Smokeless tobacco use and oral epithelial dysplasia. Cancer 1989; 64: 1527-30.
70. Andersson G, Axell T, Larsson A. Impact of consumption factors on soft tissue changes in Swedish moist snuff users: a histologic study. J Oral Pathol Med 1990; 19: 453-8.
71. Andersson G, Bjornberg G, Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J Oral Pathol Med 1994; 23: 161-7.
72. Sand L, Wallstrom M, Jalouli J, Larsson P-A, Hirsch J-M. Epstein-Barr virus and human papillomavirus in Snuff-induced lesions of the oral mucosa. Acta Otolaryngol 2000; 120: 880-4.
73. Shear M, Pindborg JJ. Verrucous hyperplasia of the oral mucosa. Cancer 1980; 46: 1855-62.
74. Tolbert PE, Shy CM, Allen JW. Micronuclei and other nuclear anomalies in buccal smears: a field test in snuff users. Am J Epidemiol 1991; 134: 840-50.
75. Roberts DM. Comparative cytology of the oral cavities of snuff users. Acta Cytol 1997; 41: 1008-14.
76. Livingston GK, Reed RN, Olson BL, Lockey JE. Induction of nuclear aberrations by smokeless tobacco in epithelial cells of human oral mucosa. Environ Mol Mutagen 1990; 15: 136-44.
77. Nair U, Obe G, Nair J et al. Evaluation of frequency of micronucleated oral mucosa cells as a marker for genotoxic damage in chewers of betel quid with or without tobacco. Mutat Res 1991; 261: 163-8.
78. Ghose UR, Parida BB. Cytological study of exfoliated buccal mucosa cells of tribes in Orissa state (India) with high risk for oral cancer. Indian J Cancer 1995; 32: 95-9.
79. Ozkul Y, Donmez H, Erenmemisoglu A, Demirtas H, Imamoglu N. Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users. Mutagenesis 1997; 12: 285-7.
80. Rosin M. Micronuclei as intermediate end points in intervention. In: GR Newell, WK Hong, ed. The biology and prevention of aerodigestive tract cancers. New York: Plenum Press, 1992; 95-103.
81. Merne M, Heinaro I, Lahteenoja H, Syrjanen S. Proliferation and differentiation markers in snuff-induced oral mucosal lesions. J Oral Pathol Med 2002; 31: 259-66.
82. Ahmed HG, Idris AM, Ibrahim SO. Study of oral epithelial atypia among Sudanese tobacco users by exfoliative cytology. Anticancer Res 2003; 23: 1943-9.
83. Ramaesh T, Mendis BR, Ratnatunga N, Thattil RO. The effect of tobacco smoking and of betel chewing with tobacco on the buccal mucosa: a cytomorphometric analysis. J Oral Pathol Med 1999; 28: 385-8.
84. Daniels TE, Chou L, Greenspan JS et al. Reduction of Langerhans cells in smokeless tobacco-associated oral mucosal lesions. J Oral Pathol Med 1992; 21: 100-4.
85. Johnson GK, Poore TK, Squier CA, Wertz PW, Reinhardt RA, Vincent SD. Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions. J Periodontal Res 1994; 29: 430-8.
86. Ibrahim SO, Bertelsen B, Kalvenes MB et al. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS 1998; 106: 959-69.
87. Luomanen M, Tiitta O, Heikinheimo K, Heinaro I, Happonen RP. Effect of snuff on cytokeratin expression in oral vestibular sulcus epithelium. J Oral Pathol Med 1997; 26: 110-6.
88. Luomanen M, Tiitta O, Heikinheimo K, Leimola-Virtanen R, Heinaro I, Happonen RP. Effect of snuff and smoking on tenascin expression in oral mucosa. J Oral Pathol Med 1997; 26: 334-8.
89. Pindborg JJ, Poulsen HE. Studies in oral leukoplakias. I. The influence of snuff upon the connective tissue of the oral mucosa. Preliminary report. Acta Pathol Microbiol Scand 1962; 55: 412-4.
90. Lyon H, Poulsen HE, Pindborg JJ. Studies in oral leukoplakias. Deposits of amyloid in the oral submucosa induced by prolonged use of snuff. Acta Pathol Microbiol Scand 1964; 60: 305-10.
91. Archard HO, Tarpley TM Jr. Clinicopathologic and histochemical characterization of submucosal deposits in snuff dipper's keratosis. J Oral Pathol 1972; 1: 3-11.
92. Idris AM, Warnakulasuriya KA, Ibrahim YE et al. Characterization of an amorphous deposit in the lamina propria in oral snuff users in the Sudan as collagen. J Oral Pathol Med 1998; 27: 157-62.
93. Johnson GK, Payne JB, Fili JM, Reinhardt RA, Organ CC, Slager SL. Development of smokeless tobacco-induced oral mucosal lesions. J Oral Pathol Med 1998; 27: 388-94.
94. Payne JB, Johnson GK, Reinhardt RA, Schmid M. Histological alterations following short-term smokeless tobacco exposure in humans. J Periodontal Res 1998; 33: 274-9.
95. Poore TK, Johnson GK, Reinhardt RA, Organ CC. The effects of smokeless tobacco on clinical parameters of inflammation and gingival crevicular fluid prostaglandin E2, interleukin-1 alpha, and interleukin-1 beta. J Periodontol 1995; 66: 177-83.
96. Andersson G, Warfvinge G. The influence of pH and nicotine concentration in oral moist snuff on mucosal changes and salivary pH in Swedish snuff users. Swed Dent J 2003; 27: 67-75.
97. Tobey NA, Schreiner VJ, Readling RD, Orlando RC. The acute effects of smokeless tobacco on transport and barrier function of buccal mucosa. J Dent Res 1988; 67: 1414-21.
98. Hirsch JM, Johansson SL. Effect of long-term application of snuff on the oral mucosa: an experimental study in the rat. J Oral Pathol 1983; 12: 187-98.
99. Johansson SL, Hirsch JM, Larsson PA, Saidi J, Osterdahl BG. Snuff-induced carcinogenesis: effect of snuff in rats initiated with 4-nitroquinoline N-oxide. Cancer Res 1989; 49: 3063-9.
100. Johansson SL, Saidi J, Osterdahl BG, Smith RA. Promoting effect of snuff in rats initiated by 4-nitroquinoline-N-oxide or 7,12-dimethylbenz(a)anthracene. Cancer Res 1991; 51: 4388-94.
101. Summerlin DJ, Dunipace A, Potter R. Histologic effects of smokeless tobacco and alcohol on the pouch mucosa and organs of the Syrian hamster. J Oral Pathol Med 1992; 21: 105-8.
102. Chen SY. Effects of smokeless tobacco on the buccal mucosa of HMT rats. J Oral Pathol Med 1989; 18: 108-12.
103. Raimondi A, Cabrini R, Itoiz ME. Ploidy analysis of field cancerization and cancer development in the hamster cheek pouch carcinogenesis model. J Oral Pathol Med 2005; 34: 227-31.
104. Sudbo J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. J Pathol 2001; 194: 303-10.
105. Vishwanatha JK, Swinney R, Banerjee AG. Modulation of annexin I and cyclooxygenase-2 in smokeless tobacco-induced inflammation and oral cancer. Mol Cell Biochem 2003; 248: 67-75.
106. Moraitis D, Du B, De Lorenzo MS et al. Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands. Cancer Res 2005; 65: 664-70.
107. Sudbo J, Reith A. Which putatively pre-malignant oral lesions become oral cancers? Clinical relevance of early targeting of high-risk individuals. J Oral Pathol Med 2003; 32: 63-70.
108. Merne M, Heikinheimo K, Saloniemi I, Syrjanen S. Effects of snuff extract on epithelial growth and differentiation in vitro. Oral Oncol 2004; 40: 6-12.
109. Murrah VA, Gilchrist EP, Moyer MP. Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg Oral Med Oral Pathol 1993; 75: 323-32.
110. Warnakulasuriya KA, MacDonald DG. Epithelial cell kinetics in oral leukoplakia. J Oral Pathol Med 1995: 24: 165-9.
111. Wang Y, Rotem E, Andriani F, Garlick JA. Smokeless tobacco extracts modulate keratinocyte and fibroblast growth in organotypic culture. J Dent Res 2001; 80: 1862-6.
112. Fox JW, Gyorfi T, Dragulev B. Effect of smokeless tobacco extract on HT 1080 cell adhesion, pp125 FAK phosphorylation and apoptosis in vitro. Toxicol 1995; 8: 339-47.
113. Mangipudy RS, Vishwanatha JK. Role of nitric oxide in the induction of apoptosis by smokeless tobacco extract. Mol Cell Biochem 1999; 200: 51-7.
114. Bagchi M, Balmoori J, Bagchi D, Ray SD, Kuszynski C, Stohs SJ. Smokeless tobacco, oxidative stress, apoptosis and antioxidants in human oral keratinocytes. Free Radic Biol Med 1998; 26; 992-1000.
115. Bernzweig E, Payne JB, Reinhardt RA, Dyer JK, Patil KD. Nicotine and smokeless tobacco effects on gingival and peripheral blood mononuclear cells. J Clin Periodontol 1998; 25: 246-52.
116. Johnson GK, Poore TK, Payne JB, Organ CC. Effect of smokeless tobacco extract on human gingival keratinocyte levels of prostaglandin E2 and interleukin-1. J Periodontol 1996; 67: 116-24.
117. Seyedroudbari SA, Khan MM. In vitro effects of smokeless tobacco extract on tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) production, and on lymphocyte proliferation. Toxicon 1998; 36: 631-7.
118. Chang T, Chowdhry S, Budhu P, Kew RR. Smokeless tobacco extracts activate complement in vitro: a potential pathogenic mechanism for initiating inflammation of the oral mucosa. Clin Immunol Immunopathol 1998; 87: 223-9.
119. Miller JA. Research in chemical carcinogenesis with Elizabeth Miller - a trail of discovery with our associates. Drug Metab Rev 1994; 26: 1-36.
120. Wray A, McGuirt WF. Smokeless tobacco usage associated with oral carcinoma. Incidence, treatment, outcome. Arch Otolaryngol Head Neck Surg 1993; 119: 929-33.
121. Stich HF, Curtis JR, Parida BB. Application of the micronucleus test to exfoliated cells of high cancer risk groups: tobacco chewers. Int J Cancer 1982; 30: 553-9.
122. Stich HF, Stich W, Parida BB. Elevated frequency of micronucleated cells in the buccal mucosa of individuals at high risk for oral cancer: betel quid chewers. Cancer Lett 1982; 17: 125-34.
123. Ghosh R, Ghosh PK. Sister chromatid exchanges in betel and tobacco chewers. Mutat Res 1984; 139: 79-81.
124. Adhvaryu SG, Dave BJ, Trivedi AH. Cytogenetic surveillance of tobacco-areca nut (mava) chewers, including patients with oral cancers and premalignant conditions. Mutat Res 1991; 261: 41-9.
125. Dave BJ, Trivedi AH, Adhvaryu SG. Cytogenetic studies reveal increased genomic damage among 'pan masala' consumers. Mutagenesis 1991; 6: 159-63.
126. Hoffmann D, Djordjevic MV, Brunnemann KD. New brands of oral snuff. Food Chem Toxicol 1991; 29: 65-8.
127. Das RK, Dash BC. Genotoxicity of 'gudakhu', a tobacco preparation. II. In habitual users. Food Chem Toxicol 1992; 30: 1045-9.
128. Kayal JJ, Trivedi AH, Dave BJ et al. Incidence of micronuclei in oral mucosa of users of tobacco products singly or in various combinations. Mutagenesis 1993; 8: 31-3.
129. Trivedi AH, Bakshi SR, Jaju RJ et al. Elevated mutagen susceptibility in cultured lymphocytes of oral cancer patients. Anticancer Res 1995; 15: 2589-92.
130. Verma A. Cytogenetic investigations on patients with oral submucous fibrosis. J Indian Med Assoc 1998; 96: 57.
131. Jaju RJ, Patel RK, Bakshi SR, Trivedi AH, Dave BJ, Adhvaryu SG. Chromosome damaging effects of pan masala. Cancer Lett 1992; 65: 221-6.
132. Patel RK, Jaju RJ, Bakshi SR, Trivedi AH, Dave BJ, Adhvaryu SG. Pan masala - a genotoxic menace. Mutat Res 1994; 320: 245-9.
133. Patel RK, Trivedi AH, Jaju RJ, Adhvaryu SG, Balar DB. Ethanol potentiates the clastogenicity of pan masala - an in vitro experience. Carcinogenesis 1994; 15: 2017-21.
134. Trivedi AH, Patel RK, Rawal UM, Adhvaryu SG, Balar DB. Evaluation of chemopreventive effects of betel leaf on the genotoxicity of pan masala. Neoplasma 1994; 41: 177-81.
135. Trivedi AH, Roy SK, Jaju RJ, Patel RK, Adhvaryu SG, Balar DB. Urine of tobacco/areca nut chewers causes genomic damage in Chinese hamster ovary cells. Carcinogenesis 1995; 16: 205-8.
136. Mahale A, Saranath D. Microsatellite alterations on chromosome 9 in chewing tobacco-induced oral squamous cell carcinomas from India. Oral Oncol 2000; 36: 199-206.
137. Saranath D, Chang SE, Bhoite LT et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer 1991; 63: 573-8.
138. Chang SE, Bhatia P, Johnson NW et al. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer 1991; 48: 409-12.
139. Warnakulasuriya KA, Chang SE, Johnson NW. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases. J Oral Pathol Med 1992; 21: 225-9.
140. Munirajan AK, Mohanprasad BK, Shanmugam G, Tsuchida N. Detection of a rare point mutation at codon 59 and relatively high incidence of H-ras mutation in Indian oral cancer. Int J Oncol 1998; 13: 971-4.
141. Lazarus P, Garewal HS, Sciubba J et al. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int J Cancer 1995; 60: 458-63.
142. Lazarus P, Idris AM, Kim J, Calcagnotto A, Hoffmann D. p53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users. Cancer Detect Prev 1996; 20: 270-8.
143. Lazarus P, Stern J, Zwiebel N, Fair A, Richie JP Jr, Schantz S. Relationship between p53 mutation incidence in oral cavity squamous cell carcinomas and patient tobacco use. Carcinogenesis 1996; 17: 733-9.
144. Xu J, Gimenez-Conti IB, Cunningham JE et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer 1998; 83: 204-12.
145. Ibrahim SO, Vasstrand EN, Johannessen AC et al. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer 1999; 81: 527-34.
146. Kannan K, Munirajan AK, Krishnamurthy J et al. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India. Int J Oncol 1999; 15: 1133-6.
147. Saranath D, Tandle AT, Teni TR et al. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol 1999; 35: 242-50.
148. Pfeifer GP, Denissenko MF, Olivier M, Tretyakova N, Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 2002; 21: 7435-51.
149. Walker DR, Bond JP, Tarone RE et al. Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene 1999; 18: 211-8.
150. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.
151. Hernandez-Boussard TM, Hainaut P. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database. Environ Health Perspect 1998; 106: 385-91.
152. Hainaut P, Hollstein M. p53 and human cancer: the first ten thousand mutations. Adv Cancer Res 2000; 77: 81-137.
153. Hainaut P, Olivier M, Pfeifer GP. TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database. Mutagenesis 2001; 16: 551-3; author reply 555-6.
154. Hainaut P, Pfeifer GP. Patterns of p53 G → T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. Carcinogenesis 2001; 22: 367-74.
155. Ibrahim SO, Johannessen AC, Idris AM et al. Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden. Int J Cancer 1996; 68: 749-53.
156. Wood MW, Medina JE, Thompson GC, Houck JR, Min KW. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Otolaryngol Head Neck Surg 1994; 111: 758-63.
157. Wedenberg C, Jonsson A, Hirsch JM. Assessment of p53 and Ki-67 expression in snuff-induced lesions. Br J Oral Maxillofac Surg 1996; 34: 409-13.
158. Schildt EB, Nylander K, Eriksson M, Hardell L, Magnusson A, Roos G. Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Int J Oncol 2003; 22: 861-8.
159. Baral R, Patnaik S, Das BR. Co-overexpression of p53 and c-myc proteins linked with advanced stages of betel-and tobacco-related oral squamous cell carcinomas from eastern India. Eur J Oral Sci 1998; 106: 907-13.
160. Murti PR, Warnakulasuriya KAAS, Johnson NW et al. p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med 1998; 27: 191-6.
161. Kulkarni V, Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol 2004; 40: 145-53.
162. Ibrahim SO, Lillehaug JR, Dolphine O, Johnson NW, Warnakulasuriya KA, Vasstrand EN. Mutations of the cell cycle arrest gene p21WAF1, but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK. Anticancer Res 2002; 22: 1445-51.
163. Sikdar N, Paul RR, Panda CK, Banerjee SK, Roy B. Loss of heterozygosity at APC and MCC genes of oral cancer and leukoplakia tissues from Indian tobacco chewers. J Oral Pathol Med 2003; 32: 450-4.
164. Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi VD, Deo MG. Amplification and overexpression of epidermal growth factor receptor gene in human oropharyngeal cancer. Eur J Cancer B Oral Oncol 1992; 28B: 139-43.
165. Kannan K, Munirajan AK, Bhuvarahamurthy V et al. FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol 2000; 36: 189-93.
166. Krishnamurthy J, Kannan K, Feng J, Mohanprasad BK, Tsuchida N, Shanmugam G. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncol 2001; 37: 222-4.
167. Nagpal JK, Mishra R, Das BR. Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis. Cancer 2002; 94: 2393-400.
168. Loro LL, Vintermyr OK, Ibrahim SO, Idris AM, Johannessen AC. Apoptosis and expression of Bax and Bcl-2 in snuff- and non-snuff associated oral squamous cell carcinomas. Anticancer Res 2000; 20: 2855-60.
169. Teni T, Pawar S, Sanghvi V, Saranath D. Expression of bcl-2 and bax in chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res 2002; 8: 109-14.